SCHEMBL8370381

SCHEMBL8370381

O=C(O)c1ccc2c(c1)CC(C(=O)O)CC2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
TDP1 Q9NUW8 2/20 0.43
SRD5A2 P31213 4/20 0.42
SRD5A1 P18405 3/20 0.42
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
POLB P06746 1/20 0.42
BLM P54132 1/20 0.42
GRM1 Q13255 1/20 0.42
MEN1 O00255 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
KMT2A Q03164 1/20 0.42
AKR1C3 P42330 1/20 0.42
KDM1A O60341 2/20 0.41
HDAC8 Q9BY41 3/20 0.40
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
HDAC6 Q9UBN7 2/20 0.39
ADRB1 P08588 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2232699 0.93 ALDH1A1 (0.56) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
SCHEMBL29559031 0.93 ALDH1A1 (0.56) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
SCHEMBL19718187 0.86 ALDH1A1 (0.53) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
SCHEMBL345292 0.81 DRD3 (0.57) MAPTMEN1KMT2ACYP4F2CYP4A11
SCHEMBL345291 0.81 DRD3 (0.57) MAPTMEN1KMT2ACYP4F2CYP4A11
SCHEMBL1107094 0.81 NPC1 (0.49) ALDH1A1MAPTPOLB
SCHEMBL7275357 0.81 ALDH1A1 (0.53) ALDH1A1TDP1SRD5A2SRD5A1KDM4E
SCHEMBL24440190 0.80 HDAC8 (0.42) ALDH1A1MAPK1HDAC8CYP4F2CYP4A11
SCHEMBL31262473 0.80 HDAC8 (0.42) ALDH1A1MAPK1HDAC8CYP4F2CYP4A11
SCHEMBL459393 0.80 DRD2 (0.60) ALDH1A1KDM4EMAPTKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999061506-A1 THERMOSETTING COATING COMPOSITIONS BASED ON POLYESTERS EASTMAN CHEMICAL COMPANY (US) 1999-12-02 WO claimed
US-9637453-B2 3-spirocyclic-6-hydroxamic acid tetralins as HDAC inhibitors FORMA THERAPEUTICS, INC. (US) 2017-05-02 US disclosed
WO-2016168598-A1 3-SPIROCYCLIC-6-HYDROXAMIC ACID TETRALINS AS HDAC INHIBITORS FORMA THERAPEUTICS, INC. (US) 2016-10-20 WO disclosed
US-20160304456-A1 3-SPIROCYCLIC-6-HYDROXAMIC ACID TETRALINS AS HDAC INHIBITORS VALO HEALTH, INC. 2016-10-20 US disclosed
US-20140031481-A1 Polyamide compositions and article manufactured therefrom SOLVAY SPECIALITY POLYMERS USA, LLC (US) 2014-01-30 US disclosed
US-20140031481-A1 Polyamide compositions and article manufactured therefrom SOLVAY SPECIALITY POLYMERS USA, LLC (US) 2014-01-30 US disclosed
WO-2012136693-A1 POLYAMIDE COMPOSITION AND ARTICLE MANUFACTURED THEREFROM SOLVAY SPECIALTY POLYMERS USA, LLC (US) 2012-10-11 WO disclosed
WO-1999061506-A1 THERMOSETTING COATING COMPOSITIONS BASED ON POLYESTERS EASTMAN CHEMICAL COMPANY (US) 1999-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304456-A1 3-SPIROCYCLIC-6-HYDROXAMIC ACID TETRALINS AS HDAC INHIBITORS HDAC1, HDAC11, HDAC6 ALDH1A1 317/4885TDP1 1283/4885SRD5A2 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.